Vol. 10. Núm. 35.
Páginas 2318-2330 (Junio 2009)

Actualización
Insuficiencia cardiaca aguda

J.J. Gómez DoblasF. Carrasco ChinchillaG. Isasti AizpuruaA. Flores
Doi : https://10.1016/S0304-5412(09)71198-9
Opciones

Identifíquese

¿Aún no es suscriptor de la revista?

Medicine
Suscribirse la revista

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960

E-mail

atencionalcliente@elsevier.com
Bibliografía
[1.]
K. Swedberg, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, et al.
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology.
Eur Heart J, (2005), 26 pp. 1115-1140
http://dx.doi.org/10.1093/eurheartj/ehi204 | Medline
[2.]
J. Remes, H. Mietinnen, A. Reunanen, K. Pyorala.
Validity of clinical diagnosis of heart failure en primary health care.
Eur Heart J, (1991), 12 pp. 315-321
Medline
[3.]
J.G.F. Cleland, F. Habib.
Assessment and diagnosis of heart failure.
J Intern Med, (1996), 239 pp. 317-325
Medline
[4.]
M. Jiménez-Navarro, J. Delgado, M. Rivera, E. Roig, J. Segovia, L. Almenar, et al.
Utilidad de los péptidos natriuréticos en la insuficiencia cardiaca.
Med Clin, (2008), 130 pp. 591-596
[5.]
M.R. Shah, V. Hasselblad, L.W. Stevenson, C. Binanay, C.M. O’Connor, G. Sopko, et al.
Impact of the pulmonary artery catheter in critically ill patients. Meta-analysis of randomized clinical trials.
JAMA, (2005), 294 pp. 1664-1670
http://dx.doi.org/10.1001/jama.294.13.1664 | Medline
[6.]
J.V. Peter, J.L. Moran, J. Phillips-Hughes, P. Graham, A.D. Bersten.
Effect of noninvasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary edema: a meta-analysis.
Lancet, (2006), 367 pp. 1155-1163
http://dx.doi.org/10.1016/S0140-6736(06)68506-1 | Medline
[7.]
M.A. Konstam, M. Gheorghiade, J.C. Burnett Jr, L. Grinfeld, A.P. Maggioni, K. Swedberg, et al.
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
JAMA, (2007), 297 pp. 1319-1331
http://dx.doi.org/10.1001/jama.297.12.1319 | Medline
[8.]
W.S. Colucci, U. Elkayam, D.P. Horton, W.T. Abraham, R.C. Bourge, A.D. Jhonson, et al.
Intravenous nesiritide, a natriuretic peptide, in the treatment of descompensated congestive heart failure. Nesiritide Study Group.
N Engl J Med, (2000), 343 pp. 246-253
http://dx.doi.org/10.1056/NEJM200007273430403 | Medline
[9.]
*Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF).
Intravenous nesiririte vs nigroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
JAMA, (2002), 287 pp. 1531-1540
Medline
[10.]
M. Kivikko, L. Lehtonen, W.S. Colucci.
Sustained hemodynanic effects of intravenous levosimendan.
Circulation, (2003), 107 pp. 81-86
Medline
[11.]
L. Lehtonen, S. Sundberg.
The contractility enhacing effect of the calcium sensitiser levosimendan is not attenuated by carvedilol in healthy subjects.
Eur J Clin Pharmacol, (2002), 58 pp. 449-452
http://dx.doi.org/10.1007/s00228-002-0500-3 | Medline
[12.]
M. Anguita Sánchez, M.G. Crespo Leiro, E. de Teresa Galván, M. Jiménez Navarro, L. Alonso-Pulpón, J. Muñiz García.
Prevalence of heart failure in the Spanish general population aged over 45 years. The PRICE Study.
Rev Esp Cardiol, (2008), 61 pp. 1041-1049
Medline
[13.]
K. Dickstein, A. Cohen-Solala, G. Filippatos, J. McMurray, P. Ponikowski, P. Poole-Wilson, et al.
Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Rev Esp Cardiol, (2008), 61 pp. 1329
[14.]
M.W. Rich.
Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults.
J Am Geriatr Soc, (1997), 45 pp. 968-974
Medline
[15.]
A.J. Muñoz García, C. Sánchez González, M.F. Jiménez Navarro, E. de Teresa Galván.
Aplicabilidad de los resultados de los ensayos clínicos de insuficiencia cardíaca a los pacientes mayores.
Med Clin (Barc), (2005), 124 pp. 558
[16.]
H.M. Krumholz, E.M. Parent, N. Tu, V. Vaccarino, Y. Wang, M.J. Radford, et al.
Readmission after hospitalization for congestive heart failure among medicare beneficiaries.
Arch Intern Med, (1997), 157 pp. 99-104
Medline
[17.]
R. Garg, S. Yusuf.
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE inhibitor Trials.
JAMA, (1995), 273 pp. 1450-1456
Medline
[18.]
F.A. Masoudi, S.S. Rathore, Y. Wang, E.P. Havranek, J.P. Curtis, J.M. Foody, et al.
National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
Circulation, (2004), 110 pp. 724-731
http://dx.doi.org/10.1161/01.CIR.0000138934.28340.ED | Medline
[19.]
The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med. 1997;336:525-33.
[20.]
M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert, et al.
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failures Study Group.
N Engl J Med, (1996), 334 pp. 1349-1355
http://dx.doi.org/10.1056/NEJM199605233342101 | Medline
[21.]
Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. 1998;339:489-97.
[22.]
M. Fu.
Beta-blocker therapy in heart failure in the elderly.
Int J Cardiol, (2008), 125 pp. 149-153
http://dx.doi.org/10.1016/j.ijcard.2007.10.010 | Medline
[23.]
G.L. Smith, J.H. Lichtman, M.B. Bracken, M.G. Shlipak, C.O. Phillips, P. DiCapua, et al.
Renal impairment and outcomes in heart failure: systematic review and meta-analysis.
J Am Coll Cardiol, (2006), 47 pp. 1987-1996
http://dx.doi.org/10.1016/j.jacc.2005.11.084 | Medline
[24.]
H. Bodoulas, C.V. Leier.
Trastornos renales y enfermedad cardiovascular. Braunwald's Cardiología.
Marban, (2004), 72 pp. 2810
[25.]
T.H. Le Jemtel, M. Padeletti, S. Jelic.
Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
J Am Coll Cardiol, (2007), 49 pp. 171-180
http://dx.doi.org/10.1016/j.jacc.2006.08.046 | Medline
[26.]
L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, M.J. de Boer, F. Cosentino, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
Eur Heart J, (2007), 28 pp. 88-136
http://dx.doi.org/10.1093/eurheartj/ehl260 | Medline
[27.]
M.M. Brooks, D. Kelley, T.J. Orchard, J. Rana, S.B. Thomas, K.S. Tyrrell, et al.
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Am Heart J, (2008), 156 pp. 528-536
http://dx.doi.org/10.1016/j.ahj.2008.05.015 | Medline
[28.]
Y.D. Tang, S.D. Katz.
Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.
Circulation, (2006), 113 pp. 2454-2461
http://dx.doi.org/10.1161/CIRCULATIONAHA.105.583666 | Medline
[29.]
S. Von Haehling, W. Doehner, S.D. Anker.
Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.
Cardiovasc Res, (2007), 73 pp. 298-330
http://dx.doi.org/10.1016/j.cardiores.2006.08.018 | Medline
Copyright © 2009. Elsevier España, S.L.. Todos los derechos reservados